The Icahn School of Medicine at Mount Sinai has launched the AI Small Molecule Drug Discovery Center, a bold endeavor that harnesses artificial intelligence (AI) to revolutionize drug development.

The new AI program will be jointly administered by the Statistics and Data Science Department and the Operations, Information ...